100 related articles for article (PubMed ID: 3547860)
1. Conversion from cyclosporine to bredinin in canine orthotopic liver transplantation.
Uchida H; Yokota K; Sato K; Masaki Y; Osakabe T; Nakayama Y; Takishima T; Aso K
Transplant Proc; 1987 Feb; 19(1 Pt 2):1290-4. PubMed ID: 3547860
[No Abstract] [Full Text] [Related]
2. Comparative studies of FK506 and cyclosporine in canine orthotopic hepatic allograft survival.
Yokota K; Takishima T; Sato K; Osakabe T; Nakayama Y; Uchida H; Aso K; Masaki Y; Ohbu M; Okudaira M
Transplant Proc; 1989 Feb; 21(1 Pt 1):1066-8. PubMed ID: 2468209
[No Abstract] [Full Text] [Related]
3. Synergistic effect of cyclosporine and mizoribine on graft survival in canine organ transplantation.
Hayashi R; Suzuki S; Shimatani K; Watanabe H; Kenmochi T; Fukuoka T; Niiya S; Amemiya H
Transplant Proc; 1990 Aug; 22(4):1676-8. PubMed ID: 2389432
[No Abstract] [Full Text] [Related]
4. Cyclosporine in transplantation of the liver in the dog.
Williams JW; Peters TG; Haggitt R; Van Voorst S
Surg Gynecol Obstet; 1983 Jun; 156(6):767-73. PubMed ID: 6344281
[TBL] [Abstract][Full Text] [Related]
5. Synergistically enhanced immunosuppressive effect by combined use of cyclosporine and mizoribine.
Amemiya H; Suzuki S; Watanabe H; Hayashi R; Niiya S
Transplant Proc; 1989 Feb; 21(1 Pt 1):956-8. PubMed ID: 2650298
[No Abstract] [Full Text] [Related]
6. Pancreaticoduodenal allotransplantation with the use of FK 506, cyclosporine, and triple-regimen immunosuppression.
Imai K; Sato K; Takishima T; Nakayama Y; Osakabe T; Yokota K; Yamagishi K; Uchida H; Hiki Y
Transplant Proc; 1990 Aug; 22(4):1655-7. PubMed ID: 1697117
[No Abstract] [Full Text] [Related]
7. Studies on immunosuppression with low-dose cyclosporine combined with mizoribine in experimental and clinical cadaveric renal allotransplantation.
Osakabe T; Uchida H; Masaki Y; Yokota K; Sato K; Nakayama Y; Ohkubo M; Kumano K; Endo T; Watanabe K
Transplant Proc; 1989 Feb; 21(1 Pt 2):1598-600. PubMed ID: 2652520
[No Abstract] [Full Text] [Related]
8. Advantages of mizoribine over azathioprine in combination therapy with cyclosporine for renal transplantation.
Mita K; Akiyama N; Nagao T; Sugimoto H; Inoue S; Osakabe T; Nakayama Y; Yokota K; Sato K; Uchida H
Transplant Proc; 1990 Aug; 22(4):1679-81. PubMed ID: 2202125
[No Abstract] [Full Text] [Related]
9. Comparative study of FK 506, cyclosporine, and triple regimen immunosuppression with FK 506, cyclosporine, and mizoribine.
Sato K; Yokota K; Matsui T; Imai K; Takishima T; Nakayama Y; Osakabe T; Yoshida M; Mieno H; Omiya H
Transplant Proc; 1991 Dec; 23(6):3296-9. PubMed ID: 1721440
[No Abstract] [Full Text] [Related]
10. A new triple-drug induction therapy with low dose cyclosporine, mizoribine and prednisolone in renal transplantation.
Kokado Y; Ishibashi M; Jiang H; Takahara S; Sonoda T
Transplant Proc; 1989 Feb; 21(1 Pt 2):1575-8. PubMed ID: 2652512
[No Abstract] [Full Text] [Related]
11. Immunosuppression with low-dose cyclosporine combined with bredinin and prednisolone.
Aso K; Uchida H; Sato K; Yokota K; Osakabe T; Nakayama Y; Ohkubo M; Kumano K; Endo T; Koshiba K
Transplant Proc; 1987 Feb; 19(1 Pt 3):1955-8. PubMed ID: 3547900
[No Abstract] [Full Text] [Related]
12. Vanishing bile duct syndrome in canine liver allotransplants.
Uchida H; Tomikawa S; Nishimura Y; Yokota K; Sato K; Osakabe T; Nakayama Y; Takishima T; Yamagishi K; Masaki Y
Transplant Proc; 1989 Feb; 21(1 Pt 1):404-6. PubMed ID: 2650161
[No Abstract] [Full Text] [Related]
13. Perioperative hyperamylasemia in cyclosporine-treated renal transplant recipients: does it have clinical significance?
Ihara H; Ogino T; Hosokawa S; Yabumoto H; Arima M; Ikoma F
Transplant Proc; 1989 Feb; 21(1 Pt 2):2147-50. PubMed ID: 2469231
[No Abstract] [Full Text] [Related]
14. [New immunosuppressives in ophthalmology].
Nakajima A
Yan Ke Xue Bao; 1985 Dec; 1(2):140-1. PubMed ID: 3880146
[No Abstract] [Full Text] [Related]
15. A comparative study of cyclosporine and its derivative SDZ IMM-125 in canine renal allografts.
Watson CJ; Metcalfe SM; St John Collier DG; Calne RY
Transplantation; 1993 Nov; 56(5):1248-50. PubMed ID: 8249131
[TBL] [Abstract][Full Text] [Related]
16. Canine liver transplantation under Nva2-cyclosporine versus cyclosporine.
Todo S; Porter KA; Kam I; Lynch S; Venkataramanan R; DeWolf A; Starzl TE
Transplantation; 1986 Mar; 41(3):296-300. PubMed ID: 3513388
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive effect of bredinin in the management of patients with renal transplantation.
Kusaba R; Otubo O; Sugimoto H; Takahashi I; Yamada Y; Yamauchi J; Akiyama N; Inou T
Proc Eur Dial Transplant Assoc; 1981; 18():420-5. PubMed ID: 7036163
[TBL] [Abstract][Full Text] [Related]
18. Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls.
Fung JJ; Todo S; Tzakis A; Demetris A; Jain A; Abu-Elmaged K; Alessiani M; Starzl TE
Transplant Proc; 1991 Feb; 23(1 Pt 1):14-21. PubMed ID: 1703682
[No Abstract] [Full Text] [Related]
19. Effectiveness of triple regimen immunosuppression in canine pancreatic allotransplantation.
Sato K; Imai K; Tadokoro F; Ishida K; Matsuzawa K; Matsui T; Ishida K; Kakita A
Transplant Proc; 1994 Aug; 26(4):2281-4. PubMed ID: 7520628
[No Abstract] [Full Text] [Related]
20. [Clinical application of bredinin].
Aso Y; Tajima A
Nihon Rinsho; 1985 Jan; 43(1):136-40. PubMed ID: 3886953
[No Abstract] [Full Text] [Related]
[Next] [New Search]
